{
    "title": "Clovis Oncology's Rubraca gets U.S. FDA approval for prostate cancer",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8324835/Clovis-Oncologys-Rubraca-gets-U-S-FDA-approval-prostate-cancer.html",
    "date": "2020-05-15",
    "keywords": [
        "cancer",
        "drug",
        "prostate",
        "mutation",
        "disease",
        "rubraca",
        "treatment",
        "castrationresistant",
        "chemotherapy",
        "mcrpc",
        "oncology",
        "inc",
        "friday",
        "food",
        "administration",
        "adult",
        "approval",
        "monotherapy",
        "brca",
        "therapy",
        "company",
        "glaxosmithkline",
        "plcs",
        "zejula",
        "plc",
        "merck",
        "co",
        "incs",
        "lynparza",
        "class",
        "dna",
        "maintenance",
        "tube",
        "peritoneal",
        "tumor",
        "stage",
        "body",
        "prognosis",
        "society",
        "harbor",
        "clovis",
        "reporting",
        "manojna",
        "maddipatla",
        "bengaluru",
        "editing",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}